Neola’s CEO to BioStock: “We are now preparing for a clinical study in the US”

After recently receiving a CB certificate for its medical device, intensive work is now underway at Neola Medical to prepare for the clinic. As part of this, a clinical pilot study will be carried out together with a neonatal ward in Sweden.

– This is a step to optimize the conditions for a successful clinical study in premature babies in the United States, CEO Hanna Sjöström tells BioStock.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/08/neolas-ceo-we-are-now-preparing-for-a-clinical-study-in-the-us/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se